Showing results (1-10 of 3,179) with videos related to

Sort By:
Pageof 318
Cell Death and Differentiation|April 14, 1999
JNK/SAPK activity contributes to TRAIL-induced apoptosisI Herr, D Wilhelm, E Meyer, et al.
The EMBO Journal|October 8, 1997
Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosisI Herr, D Wilhelm, T Böhler, et al.
International Journal of Cancer|February 6, 1999
JNK/SAPK activity is not sufficient for anticancer therapy-induced apoptosis involving CD95-L, TRAIL and TNF-alphaI Herr, D Wilhelm, T Böhler, et al.
European Journal of Immunology|March 4, 1998
TRAIL/Apo-2-ligand-induced apoptosis in human T cellsI Jeremias, I Herr, T Boehler, et al.
Blood|June 17, 1998
Inhibition of nuclear factor kappaB activation attenuates apoptosis resistance in lymphoid cellsI Jeremias, C Kupatt, B Baumann, et al.
European Cytokine Network|January 16, 1999
TRAIL induces apoptosis and activation of NFkappaBI Jeremias, K M Debatin
Blood|October 25, 2001
Cellular stress response and apoptosis in cancer therapyI Herr, K M Debatin
Molecular and Cellular Biology|December 28, 1999
c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agentsA Kolbus, I Herr, M Schreiber, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 11, 1999
CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neuronsA Martin-Villalba, I Herr, I Jeremias, et al.
Klinische Padiatrie|September 3, 1999
Betulinic acid: a new chemotherapeutic agent in the treatment of neuroectodermal tumorsS Fulda, I Jeremias, T Pietsch, et al.
Pageof 318